or Try an Advanced Search...

    Genitourinary Stocks List

    Symbol Grade Name % Change
    PFE F Pfizer, Inc. 0.09
    XTNT F Xtant Medical Holdings, Inc. -0.39
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Allotransplantation Alzheimer's Disease Animal Health Anti Infectives Back Pain Biologics Biopharmaceutical Boat Bone Bone Fracture Clinic Depressive Disorder Dietary Supplement Disease Dysfunction Endocrine Disorders Erectile Dysfunction Filler Healing Hemophilia

    Related ETFs - A few ETFs which own one or more of the above listed Genitourinary stocks.

    Symbol Grade Name Weight
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 13.4
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 6.81
    FDL A First Trust Morningstar ETF 5.94
    PJP D PowerShares Dynamic Pharmaceuticals 5.12
    THNR F Amplify Weight Loss Drug & Treatment ETF 5.03
    View all Genitourinary ETFs...
    Compare ETFs
    Compare FTXH to PJP Compare FTXH to THNR Compare PJP to THNR

        Genitourinary Stocks Recent News

        Date Stock Title
        Nov 21 PFE Major companies that are also popular short-selling stocks
        Nov 21 PFE The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and Ryanair
        Nov 21 PFE Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
        Nov 21 PFE 2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist
        Nov 21 PFE EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia
        Nov 21 PFE 2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years
        Nov 20 PFE CDC warns of an imminent spike in COVID, flu cases
        Nov 20 PFE 5 Year-to-Date Laggards to Buy Amid Solid Near-Term Upside Potential
        Nov 20 PFE Pfizer Appoints Cancer Research Head Chris Boshoff as New R&D Chief
        Nov 20 PFE Bayer Acquires Rights for Cardiovascular Drug From CYTK in Japan
        Nov 20 PFE Pfizer names head of oncology as new R&D chief
        Nov 20 PFE Pfizer Announces New Chief Scientific Officer and President, Research & Development
        Nov 20 PFE Pfizer names oncology head Chris Boshoff as R&D chief
        Nov 20 PFE Pfizer Names New R&D Chief
        Nov 20 PFE Pfizer, under pressure to change, names oncology head as new R&D chief
        Nov 20 PFE Is It Time to Sell Eli Lilly and Pfizer Stocks?
        Nov 20 PFE European Commission Approves Pfizer’s HYMPAVZI™ (marstacimab) for the Treatment of Adults and Adolescents with Severe Hemophilia A or B Without Inhibitors
        Nov 20 PFE Flagship, Pfizer alliance yields two more startup deals
        Nov 19 PFE Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rules
        Nov 19 PFE BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Allotransplantation Alzheimer's Disease Animal Health Anti Infectives Back Pain Biologics Biopharmaceutical Boat Bone Bone Fracture Clinic Depressive Disorder Dietary Supplement Disease Dysfunction Endocrine Disorders Erectile Dysfunction Filler Healing Hemophilia
        Genitourinary

        The genitourinary system, or urogenital system, are the organs of the reproductive system and the urinary system. These are grouped together because of their proximity to each other, their common embryological origin and the use of common pathways, like the male urethra. Also, because of their proximity, the systems are sometimes imaged together.The term "apparatus urogenitalis" was used in Nomina Anatomica (under Splanchnologia) but is not used in the current Terminologia Anatomica.

        More about Genitourinary
        Browse All Tags